AstraZeneca (AZNL)

12,096.00p
   
  • Change Today:
    -1.12p
  • 52 Week High: 12,668.00
  • 52 Week Low: 9,642.00
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 230,782
  • Market Cap: £152,913m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-25 Interim 28,045.00 6,529.00 346.00¢ 103.00¢

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26,617.00 3,916.00 244.00¢ 40.6 0.3 +137% 280.00¢ 2.8%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,461.5 n/a -97% 287.00¢ 2.5%
31-Dec-22 44,351.00 2,501.00 212.00¢ 71.6 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 19.7 0.1 +242% 290.00¢ 2.0%
31-Dec-24 54,073.00 8,691.00 821.00¢ 17.2 1.3 +13% 310.00¢ 2.2%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 58,046.04 18,397.03 671.04p 18.0 1.7 +10% 239.81p 0.0%
31-Dec-26 61,674.03 20,768.16 762.79p 15.9 1.2 +14% 252.23p 0.0%
31-Dec-27 65,519.76 22,755.80 844.53p 14.3 1.3 +11% 263.32p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 41.10 15.94 320.56 0.06

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,096.00p
Change Today -1.12p
% Change -0.92 %
52 Week High 12,668.00
52 Week Low 9,642.00
Volume 230,782
Shares Issued 1,264.16m
Market Cap £152,913m

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 05-Sep-2025

Time Volume / Share Price
16:29 35 @ 12,096.00p
16:29 28 @ 12,094.00p
16:29 1 @ 12,094.00p
16:29 52 @ 12,093.00p
16:29 35 @ 12,092.36p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page